Does APREPITANT Cause Thrombocytopenia? 194 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 194 reports of Thrombocytopenia have been filed in association with APREPITANT (CINVANTI). This represents 3.5% of all adverse event reports for APREPITANT.
194
Reports of Thrombocytopenia with APREPITANT
3.5%
of all APREPITANT reports
120
Deaths
147
Hospitalizations
How Dangerous Is Thrombocytopenia From APREPITANT?
Of the 194 reports, 120 (61.9%) resulted in death, 147 (75.8%) required hospitalization, and 104 (53.6%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for APREPITANT.
What Other Side Effects Does APREPITANT Cause?
Fatigue (955)
Pyrexia (913)
Dyspnoea (909)
Hypersensitivity (881)
Rash (789)
Alopecia (760)
Gastrointestinal disorder (722)
Pruritus (707)
Confusional state (696)
Glossodynia (696)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which APREPITANT Alternatives Have Lower Thrombocytopenia Risk?
APREPITANT vs APROTININ
APREPITANT vs ARANESP
APREPITANT vs ARAVA
APREPITANT vs AREDIA
APREPITANT vs ARFORMOTEROL